Imunon, Inc. is a biotechnology company focused on developing innovative therapeutic solutions for cancer and infectious diseases. The company utilizes a proprietary platform to create novel immunotherapies that enhance the body’s immune response against tumors and pathogens. Imunon is dedicated to advancing its research and product development pipeline, aiming to address critical unmet medical needs and improve patient outcomes through its specialized approach to immunotherapy and drug development. Read More
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
The data highlights promising results for IMNN-001, an IL-12 gene therapy for advanced ovarian cancer, boosting investor optimism ahead of its Phase 3 trial.
